about
Cardiac cachexia: hic et nuncCurrent and Potential Therapeutic Strategies for Hemodynamic Cardiorenal SyndromeNeuromuscular electrical stimulation of the thighs in cardiac patients with implantable cardioverter defibrillatorsUnderweight, Markers of Cachexia, and Mortality in Acute Myocardial Infarction: A Prospective Cohort Study of Elderly Medicare BeneficiariesAnimal models of anorexia and cachexia.A comparison of risk factors for mortality from heart failure in Asian and non-Asian populations: an overview of individual participant data from 32 prospective cohorts from the Asia-Pacific Region.Routine laboratory results and thirty day and one-year mortality risk following hospitalization with acute decompensated heart failureIs there a paradox in obesity?Genetic and pharmacologic blockade of central melanocortin signaling attenuates cardiac cachexia in rodent models of heart failuretrans fatty acids and systemic inflammation in heart failure.Clinical anticachexia treatments.Attenuation of depression of muscle protein synthesis induced by lipopolysaccharide, tumor necrosis factor, and angiotensin II by beta-hydroxy-beta-methylbutyrate.The link of unintentional weight loss to cardiac event-free survival in patients with heart failureMalnutrition as assessed by nutritional risk index is associated with worse outcome in patients admitted with acute decompensated heart failure: an ACAP-HF data analysis.Low-level laser therapy improves the inflammatory profile of rats with heart failure.Optimal management of cancer anorexia-cachexia syndrome.Nutrition modulation of cachexia/proteolysis.Associations between muscle-related cytokines and selected patient outcomes in the ICUSkeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormonesMedroxyprogesterone acetate in the management of cancer cachexia.Emerging biomarkers in heart failure and cardiac cachexiaDesigning Phase II B trials in sarcopenia: the best target populationThe obesity paradox is not observed in chronic heart failure patients with metabolic syndrome.Angiotensin II reduces food intake by altering orexigenic neuropeptide expression in the mouse hypothalamus.Malnutrition and associated factors among heart failure patients on follow up at Jimma university specialized hospital, Ethiopia.Cardiac cachexia.Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass.Palliation of heart failure.Time-Course of Muscle Mass Loss, Damage, and Proteolysis in Gastrocnemius following Unloading and Reloading: Implications in Chronic Diseases.Energy Metabolism and the Burden of Multimorbidity in Older Adults: Results From the Baltimore Longitudinal Study of AgingCirculating Omega-6, But Not Omega-3 Polyunsaturated Fatty Acids, Are Associated with Clinical Outcomes in Patients with Acute Decompensated Heart Failure.Cachexia Index in Advanced Non-Small-Cell Lung Cancer Patients.The possible role of myostatin in skeletal muscle atrophy and cachexia.Substrate metabolism during basal and hyperinsulinemic conditions in adolescents and young-adults with Barth syndromeCardiac cachexia at a glance.Management of end stage cardiac failure.Lower short- and long-term mortality associated with overweight and obesity in a large cohort study of adult intensive care unit patients.Murine models of atrophy, cachexia, and sarcopenia in skeletal muscle.Influences of body mass index and waist circumference on physical function in older persons with heart failureNutrition and heart failure: impact of drug therapies and management strategies.
P2860
Q26744140-D5E39A9B-F23C-4134-A373-697343933413Q26753862-0628C7F2-132E-42A2-B1D0-5A9517623A56Q28069493-B376850D-CBD4-4ED2-A37D-85E3789CCB90Q28604048-E4CC9DEE-9D9D-44D2-B37D-2FF19A422085Q30434298-621261F2-A8A5-4182-A0EE-AE4082806311Q30828094-D33EE4BE-D64F-4CE9-B8DE-C415642AE40AQ33680771-F46F1285-1312-4499-9AA9-E9ED8AE71F84Q33724123-6DF39F8B-2901-47F7-97D6-EDDBCC3FEDB9Q33919515-09BAE77A-7434-468A-9FDF-41949C5ACBE1Q33947320-EB352A62-B1E8-4BD4-948E-8CDBC5BB03C6Q33994400-BE9E8566-9BB0-4941-885C-5B00D7D368D7Q34014087-04571B24-C3B6-47FC-80F1-BB83D30C0B55Q34036472-DE0941B6-8310-442D-BB60-BB349AAF237FQ34041612-EA7A1D96-F3FA-4229-BEA9-B71F7BE747B0Q34398672-3A671485-FE49-42B5-A746-5FC87638FD93Q34417908-9B533B3C-EFCF-40A3-AAFB-F41FE6455687Q34565917-F562F44E-85A7-4856-AD67-A2FD5C16F419Q34587760-89AA0902-4165-4503-A279-67B6CB3A2E4CQ34590954-07D40F9C-7301-4A0B-AE5C-AF32E8AC8707Q34607739-9B927EB7-1993-459A-88AA-3461EFD2B69DQ34836097-4896D041-886C-4138-9BD5-C687744B34D1Q35031637-6CAF07C2-0998-46A5-99B8-AFF4B745B285Q35728712-32ADC7E9-14EC-4F34-B645-4202D87D189CQ35762656-CB1E9BE7-2689-460A-B52A-4BE52256F206Q35809504-0665380D-0273-451D-99BF-1A76DBCF884BQ35932382-46B58A58-B2FD-4AAB-980C-8C80290501AEQ36028202-69B27C68-0FC8-48DE-BA8D-C18E4A943E83Q36135133-5E34DD30-4951-44E8-881E-3F96CC475594Q36177123-38BA5DEB-A76F-48AD-A92F-2AC96F0C0076Q36181490-B372FCF0-4D8A-49C8-8C13-11963899C598Q36185678-278C8294-7E6B-440E-9400-6E130AC61452Q36267710-33C4B74C-0D4D-43D1-A33D-663B97C7359AQ36419733-4A12F6A5-4FA0-4CF0-AFEA-BEEA5A103527Q36717047-415F56A3-AF8D-478A-AC78-5003EAC7F4B3Q36836579-08F1D8F8-0560-4EB0-A2CB-38182AB68F43Q36841238-CA56D0F4-BA43-42BD-A3D5-374C1F0D080CQ36902845-B54E820B-0CEC-44CB-8EA1-418CB2524371Q36941459-4C3EA305-A6FD-439B-A28B-815422455A9FQ37098515-29FF9734-7E75-4306-B713-A1950BDCA100Q37401599-A115AC49-0CC9-4545-8471-C0BF821775E5
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The syndrome of cardiac cachexia.
@ast
The syndrome of cardiac cachexia.
@en
The syndrome of cardiac cachexia.
@nl
type
label
The syndrome of cardiac cachexia.
@ast
The syndrome of cardiac cachexia.
@en
The syndrome of cardiac cachexia.
@nl
prefLabel
The syndrome of cardiac cachexia.
@ast
The syndrome of cardiac cachexia.
@en
The syndrome of cardiac cachexia.
@nl
P1476
The syndrome of cardiac cachexia.
@en
P2093
Rakesh Sharma
P356
10.1016/S0167-5273(02)00233-4
P577
2002-09-01T00:00:00Z